What is the optimal follow-up strategy for patients with papillary thyroid microcarcinoma?

Ulla Feldt-Rasmussen
  • Nature Clinical Practice Endocrinology &#38 Metabolism, August 2006, Springer Science + Business Media
  • DOI: 10.1038/ncpendmet0227

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/ncpendmet0227

The following have contributed to this page: Professor Ulla Feldt-Rasmussen